Literature DB >> 8282609

Capillary oxygen transport during severe hypoxia: role of hemoglobin oxygen affinity.

J C Stein1, M L Ellsworth.   

Abstract

The efficacy of an increased hemoglobin oxygen affinity [decreased oxygen half-saturation pressure of hemoglobin (P50)] on capillary oxygen transport was evaluated in the hamster retractor muscle under conditions of a severely limited oxygen supply resulting from the combined effects of a 40% reduction in systemic hematocrit and hypoxic ventilation (inspired oxygen fraction 0.1). Two groups of hamsters were utilized: one with a normal oxygen affinity (untreated; P50 = 26.1 +/- 2.4 Torr) and one with an increased oxygen affinity (treated; P50 = 15.7 +/- 1.4 Torr) induced by the chronic short-term administration of sodium cyanate. Using in vivo video microscopy and image analysis techniques, we determined oxygen saturation and associated hemodynamics at both ends of the capillary network. During hypoxic ventilation, the decrease in oxygen saturation across the network was 3.6% for untreated animals compared with 9.9% for treated animals. During hypoxia, estimated end-capillary PO2 was significantly higher in the untreated animals. These data indicate that, at the capillary level, a decreased P50 is advantageous for tissue oxygenation when oxygen supply is severely compromised, because normal oxygen losses in capillaries are maintained in treated but not in untreated animals. The data are consistent with the presence of a diffusion limitation for oxygen during severe hypoxia in animals with a normal hemoglobin oxygen affinity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282609     DOI: 10.1152/jappl.1993.75.4.1601

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

Review 1.  Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication.

Authors:  Randy S Sprague; Mary L Ellsworth
Journal:  Microcirculation       Date:  2012-07       Impact factor: 2.628

Review 2.  Regulation of blood flow distribution in skeletal muscle: role of erythrocyte-released ATP.

Authors:  Mary L Ellsworth; Randy S Sprague
Journal:  J Physiol       Date:  2012-05-14       Impact factor: 5.182

3.  Diamide decreases deformability of rabbit erythrocytes and attenuates low oxygen tension-induced ATP release.

Authors:  Meera Sridharan; Randy S Sprague; Shaquria P Adderley; Elizabeth A Bowles; Mary L Ellsworth; Alan H Stephenson
Journal:  Exp Biol Med (Maywood)       Date:  2010-08-03

Review 4.  Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle.

Authors:  R S Sprague; E A Bowles; D Achilleus; M L Ellsworth
Journal:  Acta Physiol (Oxf)       Date:  2010-10-11       Impact factor: 6.311

5.  Increased hemoglobin O2 affinity protects during acute hypoxia.

Authors:  Ozlem Yalcin; Pedro Cabrales
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

Review 6.  Red cell physiology and signaling relevant to the critical care setting.

Authors:  Ahmed Said; Stephen Rogers; Allan Doctor
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

Review 7.  Hemoglobin-oxygen affinity in high-altitude vertebrates: is there evidence for an adaptive trend?

Authors:  Jay F Storz
Journal:  J Exp Biol       Date:  2016-10-15       Impact factor: 3.312

Review 8.  Role of erythrocyte-released ATP in the regulation of microvascular oxygen supply in skeletal muscle.

Authors:  M L Ellsworth; C G Ellis; R S Sprague
Journal:  Acta Physiol (Oxf)       Date:  2015-09-25       Impact factor: 6.311

Review 9.  Red Blood Cell Dysfunction in Critical Illness.

Authors:  Stephen Rogers; Allan Doctor
Journal:  Crit Care Clin       Date:  2020-02-11       Impact factor: 3.598

Review 10.  Erythrocytes: oxygen sensors and modulators of vascular tone.

Authors:  Mary L Ellsworth; Christopher G Ellis; Daniel Goldman; Alan H Stephenson; Hans H Dietrich; Randy S Sprague
Journal:  Physiology (Bethesda)       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.